Monthly Archives: February 2012

3D Cell Culture – Rotary Cell Culture System Promotional Video from the ’90s – Video


28-02-2012 13:22 Synthecon’s first promotional video for the Rotary Cell Culture Systems. Although the video quality may seem “vintage,” the explanations given in the video provide a sound foundation for understanding the goal of our products Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , | Comments Off

Cell>Point Executes Asia Pacific License with HYUN IMC for Cancer and Heart Disease Diagnostic Imaging Agent …

CENTENNIAL, Colo.–(BUSINESS WIRE)– Cell> Point today announced that it had entered into a licensing agreement for the countries of South Korea, Taiwan, Malaysia, Vietnam, and the Philippines with HYUN IMC Co., Ltd., headquartered in Seoul, South Korea. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , | Comments Off

Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical …

SAN DIEGO, CA and PORTLAND, OR–(Marketwire -02/28/12)- Medistem Inc. (Pinksheets: MEDS.PK – News) announced today its Annual “Evening with Medistem” Event will take place in Portland, Oregon on March 7th, 2012. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , | Comments Off

Stem Cell Therapy Book ~ Enhance Your Stem Cells – Video


28-02-2012 12:18 FREE STEM CELL BOOK! myjdimlm.com PUBLIC SERVICE VIDEO Home of JDI Multi Vitamin-Minerals with Stem Cell Nutrition Support Overcome the Aging Process. As we age, the body releases fewer and fewer adult stem cells which are the body’s rebuilding tools. Stem cell nutrition helps overcome the aging process by promoting the release of additional adult stem cells in the body. Continue reading

Posted in Cell Therapy | Tagged , , , , , , , , , , , , , , | Comments Off

Stem Cell Therapy Procedure and Outcome – Video


28-02-2012 14:48 Albert Rodriguez, MD administers stem cell therapy for Hereditary Spastic Paraplegia. stemcelldrR.com, email airpainmd@aol.com Continue reading

Posted in Cell Therapy | Tagged , , , , , , | Comments Off

Parents want sickle cell anemia program to stay

Advocates for patients with sickle cell anemia at the Ottawa Hospital say they want to see to see a pilot project that provides extra care extended into a permanent program. The Ottawa Hospital Academic Medical Organization funded the one-year grant to pay for the salary of a nurse who coordinates the care or 100 patients with sickle cell anemia, a genetic blood disorder that can lead to a number of health complications. Funding for the project ends in August and patients are worried it won’t continue Continue reading

Posted in Cell Medicine | Tagged , , , , , , , | Comments Off

Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)

SUNRISE, Fla., Feb. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , , , , | Comments Off

Biogen seeks approval of oral multiple sclerosis treatment

Biogen Idec, a biotechnology company specializing in drugs for neurological and autoimmune disorders and cancer, has submitted an application to the U.S. Food and Drug Administration for approval of BG-12, an oral therapeutic drug designed to treat multiple sclerosis. The Weston-based company said BG-12 demonstrated “significant reductions in MS disease activity” during its comprehensive development program Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , , , , | Comments Off

March is National MS Education and Awareness Month

Allsup promotes awareness and helps individuals be “At Their Best with MS” Belleville, Ill. (PRWEB) February 28, 2012 Multiple sclerosis (MS) is an often overlooked and misunderstood disease, according to the Multiple Sclerosis Foundation (MSF). Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , | Comments Off

Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis

WESTON, Mass.–(BUSINESS WIRE)– Today Biogen Idec (NASDAQ: BIIB – News) announced the company has submitted a New Drug Application (NDA) to the U.S. Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , | Comments Off